The real-life variability of CA 125 in ovarian cancer patients.

被引：0
|
作者：
Markman, M [1 ]
Tso, E [1 ]
Van Lente, F [1 ]
Elson, P [1 ]
Odar, D [1 ]
Peterson, G [1 ]
Kulp, B [1 ]
Sessana, M [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5014
引用
收藏
页码：452S / 452S
页数：1
相关论文
共 50 条
  • [1] The "real-life" variability of CA-125 in ovarian cancer patients
    Tso, Elisa
    Elson, Paul
    VanLente, Fred
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 141 - 144
  • [2] Exposure–Response Analyses of Olaparib in Real-Life Patients with Ovarian Cancer
    Ma Ida Mohmaed Ali
    Maaike A. C. Bruin
    Vincent O. Dezentjé
    Jos H. Beijnen
    Neeltje Steeghs
    Alwin D. R. Huitema
    Pharmaceutical Research, 2023, 40 : 1239 - 1247
  • [3] Exposure-Response Analyses of Olaparib in Real-Life Patients with Ovarian Cancer
    Ali, Ma Ida Mohmaed
    Bruin, Maaike A. C.
    Dezentje, Vincent O.
    Beijnen, Jos H.
    Steeghs, Neeltje
    Huitema, Alwin D. R.
    PHARMACEUTICAL RESEARCH, 2023, 40 (05) : 1239 - 1247
  • [4] Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting"
    van Wagensveld, Lilian
    Colomban, Olivier
    van der Aa, Maaike A.
    Freyer, Gilles
    Sonke, Gabe S.
    Kruitwagen, Roy F. P. M.
    You, Benoit
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (03)
  • [5] Recent changes in overall survival of real-life stage IV colorectal cancer patients.
    Hamers, Patricia
    Bos, Amanda C. R. K.
    May, Anne Maria
    Punt, Cornelis J. A.
    Koopman, Miriam
    Vink, Geraldine R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] CA 125 - Serum determinations in patients with ovarian cancer
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4789 - 4790
  • [7] The Bayer Immuno 1™ CA 125 II™ assay:: An automated assay for the clinical management of ovarian cancer patients.
    Arrigo, L
    Pierre, Y
    Berchuck, A
    Morris, DL
    Yeung, KK
    Very, DL
    CLINICAL CHEMISTRY, 1998, 44 : A44 - A44
  • [8] The Importance of the CA-125 Value in Patients with Ovarian cancer
    Bachmann, C.
    Bachmann, S.
    Grischke, E. M.
    Fehm, T.
    Wallwiener, D.
    Staebler, A.
    Solomayer, E. F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 733 - 733
  • [9] CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
    Hegde, Mangala
    Chianeh, Yousef Rezaei
    Shetty, Jeevan
    Fernandes, Donald J.
    Rao, Pragna
    CUKUROVA MEDICAL JOURNAL, 2015, 40 (03): : 510 - 516
  • [10] A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients.
    Sacca, F.
    Pane, C.
    Espinosa, P.
    Sormani, M.
    Signori, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 569 - 570
12345